r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

OL

ORBIMED ADVISORS LLC

Insider · Director · BLSM

ORBIMED ADVISORS LLC files insider transactions with the SEC as a director of BlossomHill Therapeutics (BLSM). We hold 23 disclosed purchases and sales filed since 23 February 2006, 7 of them in the last 90 days.

  • Files forBLSM
  • Disclosed buys and sells23 in all, 7 in the last 90 days
  • Last disclosure12 August 2026

Positions held

20 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 10 August 2026 — 10 August 2026Director · BlossomHill Therapeutics (BLSM)5 Form 4 lines · source: SEC Form 4
  • Filed 7 August 2026 — 7 August 2026Director and 10% owner · Braveheart Bio (BRVE)4 Form 4 lines · source: SEC Form 4
  • Filed 27 July 2026 — 27 July 2026Director · Scribe Therapeutics (SCTX)3 Form 4 lines · source: SEC Form 4
  • Filed 24 November 2025 — 7 July 2026Director · Sionna Therapeutics (SION)16 Form 4 lines · source: SEC Form 4
  • Filed 15 June 2026 — 22 June 202610% owner · Enliven Therapeutics (ELVN)6 Form 4 lines · source: SEC Form 4
  • Filed 8 June 2026 — 11 June 2026Director · Shattuck Labs (STTK)6 Form 4 lines · source: SEC Form 4
  • Filed 28 May 2026 — 28 May 2026Director and 10% owner · Q32 Bio (QTTB)2 Form 4 lines · source: SEC Form 4
  • Filed 27 March 2020 — 21 April 2026Director and 10% owner · Prelude Therapeutics (PRLD)14 Form 4 lines · source: SEC Form 4
  • Filed 16 April 2026 — 16 April 202610% owner · Traws Pharma (TRAW)4 Form 4 lines · source: SEC Form 4
  • Filed 14 April 2026 — 14 April 2026Director · ImageneBio (IMA)2 Form 4 lines · source: SEC Form 4
  • Filed 27 June 2023 — 8 April 202610% owner · Adicet Bio (ACET)10 Form 4 lines · source: SEC Form 4
  • Filed 25 September 2020 — 10 September 202510% owner · PMV Pharmaceuticals (PMVP)13 Form 4 lines · source: SEC Form 4
  • Filed 20 July 2023 — 8 August 2025Director · Turnstone Biologics (TSBX)7 Form 4 lines · source: SEC Form 4
  • Filed 4 August 2023 — 25 July 2025Director · ImageneBio (IKNA)3 Form 4 lines · source: SEC Form 4
  • Filed 29 March 2016 — 27 June 2025Director and 10% owner · Corvus Pharmaceuticals (CRVS)21 Form 4 lines · source: SEC Form 4
  • Filed 20 January 2022 — 26 June 202510% owner · Passage BIO (PASG)16 Form 4 lines · source: SEC Form 4
  • Filed 19 April 2024 — 14 May 202510% owner · NeuroPace (NPCE)9 Form 4 lines · source: SEC Form 4
  • Filed 15 February 2023 — 24 March 2025Director · Disc Medicine (IRON)6 Form 4 lines · source: SEC Form 4
  • Filed 15 October 2024 — 15 October 2024Director and 10% owner · Upstream Bio (UPB)8 Form 4 lines · source: SEC Form 4
  • Filed 16 September 2024 — 16 September 2024Director and 10% owner · MBX Biosciences (MBX)7 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.